Protective Effects of Rosuvastatin in Experimental Renal Failure Rats via Improved Endothelial Function

Biological Research for Nursing

Volumn 15, Issue 3, 2013, Pages 356-364

  Liu, Yong zhen ^a   Liu, Min ^a   Zhang, Yi ming ^a   Kang, Li ^a   Chen, Ping zhi ^b   Wang, Ze feng ^a   Feng, Yuan ^c   Zheng, Jun hua ^a  

^a TONGJI UNIVERSITY   (China)

^b Nursing Association in Shanghai   (China)

^c THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

5 6 nephrectomy; chronic kidney disease; endothelial dysfunction; rosuvastatin

Indexed keywords

FLUOROBENZENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; ROSUVASTATIN; SULFONAMIDE;

5/6 NEPHRECTOMY; ANIMAL; ARTICLE; CHRONIC KIDNEY DISEASE; ENDOTHELIAL DYSFUNCTION; FISCHER 344 RAT; KIDNEY FAILURE; MALE; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

5/6 NEPHRECTOMY; CHRONIC KIDNEY DISEASE; ENDOTHELIAL DYSFUNCTION; ROSUVASTATIN;

ANIMALS; FLUOROBENZENES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PYRIMIDINES; RATS; RATS, INBRED F344; REAL-TIME POLYMERASE CHAIN REACTION; RENAL INSUFFICIENCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFONAMIDES;

EID: 84878755950     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800411432630     Document Type: Article

References (24)

1. Alemzadeh R.,Fledelius C.,Bodvarsdottir T.,Sturis J.Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats.Metabolism. 2004;53:441-447.
2. Feng Y.,Wang Y.,Xiong J.,Liu Z.,Yard B.,Lang F.Enhanced expression of serum and glucocorticoid-inducible kinase-1 in kidneys of L-NAME-treated rats.Kidney Blood Pressure Research. 2006;29:94-99.
3. Govers R.,van der Sluijs P.,van Donselaar E.,Slot J. W.,Rabelink T. J.Endothelial nitric oxide synthase and its negative regulator caveolin-1 localize to distinct perinuclear organelles.Journal of Histochemistry & Cytochemistry. 2002;50:779-788.
4. Knight S. F.,Quigley J. E.,Yuan J.,Roy S. S.,Elmarakby A.,Imig J. D.Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet.Hypertension. 2008;51:352-359.
5. Kosch M.,Barenbrock M.,Suwelack B.,Schaefer R. M.,Rahn K. H.,Hausberg M.Effect of a 3-year therapy with the 3-hydroxy-3-methylglutaryl coenzyme a reductase-inhibitor fluvastatin on endothelial function and distensibility of large arteries in hypercholesterolemic renal transplant recipient.American Journal of Kidney Disease. 2003;41:1088-1096.
6. Ludman A.,Venugopal V.,Yellon D. M.,Hausenloy D. J.Statins and cardioprotection-More than just lipid lowering?.Pharmacology & Therapeutics. 2009;122:30-43.
7. Mäki-Petäjä K. M.,Wilkinson I. B.Anti-inflammatory drugs and statins for arterial stiffness reduction.Current Pharmaceutical Design. 2009;15:290-303.
8. Malyszko J.Mechanism of endothelial dysfunction in chronic kidney disease.Clinica Chimica Acta. 2010;411:1412-1420.
9. Merhaut S.,Trupp R. J.Cardiorenal dysfunction.AACN Advances in Critical Care. 2010;21:357-364.
10. Morgan C.,Zappitelli M.,Gill P.Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: A systematic review.Critical Care. 2009;13:R165.
11. Palmer Alves T.,Lewis J.Racial differences in chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States: a social and economic dilemma.Clinical Nephrology. 2010;74:S72-S77.
12. Pfaffl M. W.,Horgan G. W.,Dempfle L.Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR.Nucleic Acids Research. 2002;30:e36.
13. Racusen L. C.,Solez K.,Colvin R. B.,Bonsib S. M.,Castro M. C.,Cavallo T.,Yamaguchi Y., et al.The Banff 97 working classification of renal allograft pathology.Kidney International. 1999;55:713-723.
14. Reisin E.,Ebenezer P. J.,Liao J.,Lee B. S.,Larroque M.,Hu X.,Francis J.Effect of the HMG-CoA reductase inhibitor rosuvastatin on early chronic kidney injury in obese Zucker rats fed with an atherogenic diet.American Journal of the Medical Sciences. 2009;338:301-309.
15. Santoro D.,Bellinghieri G.,Conti G.,Pazzano D.,Satta E.,Costantino G.,Savica V.Endothelial dysfunction in chronic renal failure.Journal of Renal Nutrition. 2010;20:S103-S108.
16. Schulz A.,Litfin A.,Kossmehl P.,Kreutz R.Genetic dissection of increased urinary albumin excretion in the Munich Wistar Frömter rat.Journal of the American Society of Nephrology. 2002;13:2706-2714.
17. Sheffield J. B.,Graff D.,Li H. P.A solid phase method for the quantitation of protein in the presence of SDS and other interfering substances.Analytical Biochemistry. 1987;166:49-54.
18. Silverstein D. M.Inflammation in chronic kidney disease: Role in the progression of renal and cardiovascular disease.Pediatric Nephrology. 2009;24:1445-1452.
19. Sugaru E.,Nakagawa T.,Ono-Kishino M.,Nagamine J.,Tokunaga T.,Kitoh M.,Taiji M.SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.American Journal of Physiology-Renal Physiology. 2006;290:F813-F820.
20. Szabó A.,Schmutz A.,Pesian S.,Schmidt-Gayk H.,Ritz E.,Reichel H.Regulation of intestinal vitamin D receptor expression in experimental uraemia: Effects of parathyroidectomy and administration of PTH.Nephrology Dialysis Transplantation. 1998;13:340-349.
21. Wang H.,Wang A. X.,Liu Z.,Chai W.,Barrett E. J.The trafficking/interaction of eNOS and caveolin-1 induced by insulin modulates endothelial nitric oxide production.Molecular Endocrinology. 2009;23:1613-1623.
22. Xu Q.,Prabhu A.,Xu S.,Manigrasso M. B.,Maric C.Dose-dependent effects of dihydrotestosterone in the streptozotocin-induced diabetic rat kidney.American Journal of Physiology-Renal Physiology. 2009;297:F307-F315.
23. Zhang W.,Liu M.,Wu Y.,Zhu P.,Yin C.,Zhang W.,Gu M.Protective effects of atorvastatin on chronic allograft nephropathy in rats.Journal of Surgical Research. 2007;143:428-436.
24. Zhao X. Y.,Li L.,Zhang J. Y.,Liu G. Q.,Chen Y. L.,Yang P. L.,Liu R. Y.Atorvastatin prevents left ventricular remodeling in spontaneously hypertensive rats.International Heart Journal. 2010;51:426-431.